Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.

[1]  O. Monni,et al.  New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. , 2001, Cancer research.

[2]  S. Paik,et al.  HER-2 and choice of adjuvant chemotherapy in breast cancer. , 2001, Seminars in oncology.

[3]  Careen K. Tang,et al.  Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. , 2001, Cancer research.

[4]  M. Shekhar,et al.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.

[5]  O. Dietze,et al.  Co‐expression of tenascin‐C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins , 2001, The Journal of pathology.

[6]  Careen K. Tang,et al.  KAI1 protein is down-regulated during the progression of human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  G. A. Whitmore,et al.  Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[9]  Karsten Schlüns,et al.  Patterns of chromosomal imbalances in invasive breast cancer , 2000, International journal of cancer.

[10]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[11]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[12]  D. Taupin,et al.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Barrett,et al.  Loss of KAI1 expression in the progression of colorectal cancer. , 1999, Cancer research.

[14]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[15]  G. Landes,et al.  Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.

[16]  J. Cerhan,et al.  Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  D. Slamon,et al.  Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. , 1999, Nucleic acids research.

[18]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Barrett,et al.  Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. , 1999, The American journal of pathology.

[21]  M. Ogawa,et al.  Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase. , 1999, Journal of experimental & clinical cancer research : CR.

[22]  D. Miles,et al.  Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer , 1999, British Journal of Cancer.

[23]  M. Ogawa,et al.  Nuclear Localization of Brain-type Glycogen Phosphorylase in Some Gastrointestinal Carcinoma , 1998, The Histochemical Journal.

[24]  A. Takaoka,et al.  Reduced Invasive and Metastatic Potentials of KAI1‐transfected Melanoma Cells , 1998, Japanese journal of cancer research : Gann.

[25]  W. Bodmer,et al.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. May,et al.  Review: Trefoil Proteins: Their Role in Normal and Malignant Cells , 1997 .

[27]  J. Barrett,et al.  Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer , 1997, The Prostate.

[28]  F. May,et al.  Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells , 1997, The Journal of pathology.

[29]  M. Hendrix,et al.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.

[30]  D. Horsfall,et al.  Vimentin expression is not associated with poor prognosis in breast cancer , 1996, International journal of cancer.

[31]  F. Ciardiello,et al.  Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes , 1995, International journal of cancer.

[32]  M. Sliwkowski,et al.  HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.

[33]  J. Taylor‐Papadimitriou,et al.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Gusterson,et al.  Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[36]  A. Al Moustafa,et al.  The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[37]  F. May,et al.  Trefoil proteins: their role in normal and malignant cells. , 1997, The Journal of pathology.

[38]  松崎 法成.  Novel subtyping of intestinal metaplasia in the human stomach : brain-type glycogen phosphorylase expression in the proliferate zone and its relationship with carcinogenesis , 1997 .

[39]  C R King,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  K. Weber,et al.  Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. , 1990, The American journal of pathology.